Aclarion, Inc. filings document material events and governance for a commercial-stage healthcare technology issuer with Nasdaq-listed common stock and warrants. Recent Form 8-K reports cover capital actions such as a share repurchase authorization, executive finance leadership transition, employment agreement terms and Regulation FD communications.
The company's regulatory record also includes annual meeting and stockholder-vote disclosures, director elections, emerging growth company status and common stock information. These filings frame Aclarion's public reporting around its healthcare technology business, governance controls, officer appointments and capital-structure actions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many ACLARION (ACONW) SEC filings are available on StockTitan?
StockTitan tracks 18 SEC filings for ACLARION (ACONW), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for ACLARION (ACONW)?
The most recent SEC filing for ACLARION (ACONW) was filed on July 7, 2025.